Study of the applicability of a compressor nebulizer for the introduction of aerosols into the respiratory tract of small laboratory animals

E.A. Roshchina,  ORCID 0000-0002-9257-4241
А.А. Zueva, ORCID 0000-0002-2996-0748

Research and manufacturing company «Home оf Pharmacy»,
188663, Russia, Leningrad oblast, Vsevolozhskiy district, Kuzmolovskiy t.s., Zavodskaya st. 3-245



In preclinical studies, when assessing the safety and pharmacological activity of drugs, as well as pharmaceutical substances, it is often necessary to test drugs for inhalation administration. Today, there is a fairly wide range of specialized equipment that allows this route of administration to be provided for both small and large laboratory animals. In most cases, inhalation units are expensive and large-sized.

As an alternative to large-sized inhalation exposure systems, in this research, we consider a compressor (jet) nebulizer designed for the timely treatment of bronchial asthma, chronic obstructive pulmonary diseases and other diseases of the respiratory system. The operation of this type of nebulizer is based on the Bernoulli effect, which produces an aerosol with a fixed particle size. It also allows you to spray most substances with a complex chemical structure. The compressor nebulizer is used in experimental studies for the induction of pathologies such as asthma, as well as for the formation of anaphylactic shock using ovalbumin. In literary sources, there are various methodological approaches using a nebulizer. Inhalation administration to Wistar rats was carried out in two ways (in an inhalation chamber and in a mask) at different exposures (5, 10, 15 and 20 minutes). For inhalation, saline was used which was stained with Evans blue using the imaging penetration assessment. The experiment showed that inhalation, carried out by placing the animal in the inhalation chamber, did not lead to the ingress of the spray solution into the respiratory tract. In contrast, when inhaled in the mask, staining of the lungs was recorded, which indicates the penetration aerosol into the respiratory tract. Thus, the compressor nebulizer can be used for the use of various diseases, in cases where the exact dosage of the pathological inducer administered by inhalation is not required.

Full text avaliable in Russain only 


The study was performed without external funding.

Autors’ contributions

Е.А. Roshchina – design and conduct research, work with literary sources, writing the text of the article.

A.A. Zueva – work with animals.

Conflict of interest

The authors declare no conflict of interest.


  1. Закирова А.М., Пикуза О.И., Шаяпова Д.Т., Рашитова Э.Л., Волянюк Е.В. Эффективность небулайзеров в терапии респираторного поражения дыхательных путей у детей разных возрастных групп // Медицинский совет. – 2020; 1: 152-157. [Zakirova A.M., Pikuza O.I., Shayapova D.T., Rashitova E.L. Volyanyuk E.V. Effectiveness of nebulizers in the treatment of respiratory tract infections in children of different ages // Meditsinskiy sovet. – 2020; 1: 152-157. (In Russ.)] DOI: 10.21518/2079-701X-2020-1-152-157.
  2. Wong B.A. Inhalation Exposure Systems: Design, Methods and Operation // Toxicologic Pathology. – 2007; 35: 3–14. DOI: 10.1080/01926230601060017.
  3. Терехова Е.П., Бодня О.С., Терехов Д.В., Ненашева Н.М. Возможности небулайзерной терапии бронхиальной астмы // Эффективная фармакотерапия. – 2018; 6: 30-39. [Terekhova Ye.P., Bodnya O.S., Terekhov D.V., Nenasheva N.M. Possibilities of bronchial asthma nebulizer therapy // Effective pharmacotherapy. – 2018; 6: 30-39 (In Russ.)].
  4. Малахов А.Б., Колосова Н.Г., Гребенева И.В. Выбор ингалятора (небулайзера) в клинической практике: вопросы и ответы // Педиатрия (Прил. к журн. Consilium Medicum). – 2018; 6: 55–58. [Malakhov A.B., Kolosova N.G., Grebeneva I.V. The choice of an inhaler (nebulizer) in clinical practice: questions and answers. Pediatrics (Suppl. Consilium Medicum). – 2018; 3: 55–58.] DOI: 10.26442/2413-8460_2018.3.55-58.
  5. Kamaruzaman N.A., Sulaiman S.A., Kaur G., Yahaya B. Inhalation of honey reduces airway inflammation and histopathological changes in a rabbit model of ovalbumin-induced chronic asthma // BMC Complementary and Alternative Medicine. – 2014; 14 (176). DOI: 10.1186/1472-6882-14-176.
  6. Nabe T., Shinoda N., Yamashita K., Yamada M., Yamamura H., Kohno S. Comparative studies on nebulizers for antigen inhalation in experimental asthma // Allergology International. – 1997; 46 (4): 261-267. DOI: 10.2332/allergolint.46.261.
  7. Lowe A.P.P., Thomas R.S., Nials A.T., Kidd E.J., Broadley K.J., Ford W.R. LPS exacerbates functional and inflammatory responses to ovalbumin and decreases sensitivity to inhaled fluticasone propionate in a guinea pig model of asthma // British Journal of Pharmacology. – 2015; 172: 2588-2603. DOI: 10.1111/bph.13080.
  8. Zhang G., Lin R., Wiggers M.E., Lee L. Sensitizing Effects of Chronic Exposure and Acute Inhalation of Ovalbumin Aerosol on Pulmonary C-fibers in Rats // Journal of Applied Physiology. – 2008; 105 (1): 128-138. DOI: 10.1111/bph.13080.
  9. Thakur V.R., Khuman V, Beladiya J.V., Chaudagar K.K., Mehta A.A. An experimental model of asthma in rats using ovalbumin and lipopolysaccharide allergens // Heliyon. – 2019; 5 (11). DOI: 10.1016/j.heliyon.2019.e02864.
  10. Chiang P., Hu Y., Blom J.D., Thompson D.C. Evaluating the Suitability of Using Rat Models for Preclinical Efficacy and Side Effects with Inhaled Corticosteroids Nanosuspension Formulations // Nanoscale Res Lett. – 2010; 5: 1010-1019. DOI: 10.1007/s11671-010-9597-y.
  11. Kianmehr M., Ghorani V., Boskabady M.H. Animal Model of Asthma, Various Methods and Measured Parameters: A Methodological Review // Iranian Journal of Allergy, Asthma, and Immunology. – 2016; 15 (6): 445-457.
  12. Salmon M., Walsh D.A., Huang T., Barnes P.J., Leonard T.B., Hay D.W.P., Chung K.F. Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats // British Journal of Pharmacology. – 1999; 127: 1151-1158. DOI: 10.1038/sj.bjp.0702669.
  13. Mahmoudabady М., Neamati A., Somayyeh Vosooghi, Heydar Aghababa. Hydroalcoholic extract of Crocus sativus effects on bronchial inflammatory cells in ovalbumin sensitized rats // Avicenna Journal of Phytomedicine. – 2013; 3 (4): 356-363.
  14. European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes. European Treaty Series - No. 123. – 1896: 11.

You may be interested